Crew Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-529
Closed -$205K – 119
2026
Q2
$205K Buy
+529
New +$196K 0.11% 110
2025
Q3
– Sell
-529
Closed -$206K – 118
2025
Q2
$206K Sell
529
-49
-8% -$19.7K 0.15% 111
2025
Q1
$251K Buy
578
+11
+2% +$4.42K 0.21% 124
2024
Q4
$209K Hold
567
– – 0.17% 138
2024
Q3
$295K Sell
567
-5
-0.9% -$2.67K 0.24% 104
2024
Q2
$310K Hold
572
– – 0.25% 92
2024
Q1
$297K Buy
+572
New +$284K 0.24% 95

Other funds holding ELV

Crew Capital Management's ELV Position: Q3 2026 in Review

Crew Capital Management sold out of Elevance Health (ELV) in Q3 2026, closing a stake of 529 shares — an estimated $205K sold.

Crew Capital Management first reported a position in ELV in Q1 2024 and held it in 7 quarters. The position peaked at $310K in Q2 2024. 1,366 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Crew Capital Management reported no remaining Elevance Health position as of Q3 2026 after selling out during the quarter.
  • Crew Capital Management sold 529 Elevance Health shares in Q3 2026, an estimated $205K.
  • Crew Capital Management first reported a position in Elevance Health in Q1 2024 and held it in 7 quarters.
  • Crew Capital Management's Elevance Health position peaked at $310K in Q2 2024.
  • 1,366 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Crew Capital Management's 13F filing for Q3 2026, filed 28 Oct 2026.